TruScreen Achieves Significant Milestones with Distributors

Thu, Mar 03 2022 08:46 am

NZX/ASX Announcement

3 March 2022

TruScreen achieves significant milestones with Distributors

Key Highlights
• TruScreen achieves National Pricing Approval in China
• Zimbabwe National Aids Council project generates new SUS sales contract
• Distributors incentivised to boost sales by new share options issue
• Appointment of Marketing and Communications Manager

TruScreen Group Limited (NZX/ASX: TRU) (‘TruScreen’ or ‘the Company’) is pleased to provide the following market update, outlining the Company’s progress.

TruScreen achieves National Pricing Approval in China

In December 2021, The National Health Commission of the People’s Republic of China published an updated Technical Specification for National Procedures and Services in Medicine on the Healthcare Standard website. Following a one-month exposure period, these procedures are implemented and distributed to all Provincial Health Commissions in China.

TruScreen cervical cancer screening system is now included in these guidelines with the result that it is no longer required for provinces to go through clinical and technical evaluation prior to seeking National Health Commission’s approval. TruScreen currently has national pricing approval in 7 provinces and a further 10 provincial applications are pending. The inclusion of TruScreen in the updated Technical Specifications will shorten the purchasing cycle by Provincial Health commissions and will accelerate the entry of TruScreen cervical cancer screening system in all remaining provinces.

Zimbabwe places March 2022 order for 10,800 SUS units

TruScreen also announce that the initial pilot phase of the Zimbabwe National AIDS Council cervical cancer screening project was successfully completed in late calendar year 2021.

The project was highly significant in relation to Zimbabwe’s healthcare challenges, in cervical cancer. Seven selected clinics screened 500 women over a one-month period. Following the completion of the initial pilot phase TruScreen secured a sales contract with Zimbabwe National AIDS Council for 10,800 single-use senor (SUS) units to complete the ongoing pilot project.

The link between HIV AIDs and cervical cancer is that women diagnosed with HIV have a higher risk of later developing cervical cancer. With Zimbabwe having one of the higher HIV rates in the world and Africa with an above-average rate of cervical cancer, the effective and low-cost Truscreen cervical screening technology is a key response in its healthcare strategy.

Distributors incentivised to boost sales by new share options issue

TruScreen has today issued 2,250,000 share options to distributors with exercise price of NZ$0.10 and an expiry date of 7 September 2024.

The share options were approved by shareholders at the annual shareholders meeting on 7 September 2021 and issued to seven international distributors. This initiative together with regular distributor conferences are designed to build the TruScreen distributor community, enabling distributors to share and leverage off each other’s success. In the process, further aligning their interests with TruScreen.

Appointment of Marketing and Communications Manager

TruScreen recently appointed Hubert Chan, a senior marketing executive with 15+ years’ experience in the medical device field, as its Marketing & Communications Manager.

During his time working in the medical device market segment, Hubert held a number of global head office-, regional- and national-based positions located in Australia, USA, Switzerland and UK. These roles specialised in pre-launch, launch and post-launch activities for a range of medical device products, including cochlear implants, orthopaedics, wound management, endoscopy, and surgical instruments.

Hubert holds a Master of Business Administration from the Australian Graduate School of Management and a Bachelor of Medical Science (Honours) from the University of Sydney.

Hubert’s skills and experience will drive the Company in marketing strategy, product lifecycle management and global medical device markets, as the Company further expands the geographic footprint. The TruScreen technology is ideal for communities unable to access conventional, laboratory dependent, and other screening methods.

TruScreen CEO Juliet Hull said: “The ability of TruScreen to accelerate pricing approvals in all provinces of China is a major step forward in our key market. The Zimbabwe contract is also a validation of the concerted efforts of TruScreen and its distributor network to expand to target markets overseas.

With an eye to continued growth in our revenue base, we are pleased to launch the international distributor-specific share options plan that incentivises distributors to bolster TruScreen product sales.

Finally, I would personally like to welcome Hubert to the TruScreen team. He will be a key asset as the Company continues to grow its geographic footprint.”

This announcement has been approved by the Board.

For more information, visit or contact:
Juliet Hull
Chief Executive Officer

Guy Robertson
Chief Financial Officer

Julia Maguire
Investor Relations
+61 2 8999 3699

Announcement PDF

Markets News

News in Brief FREE
Cannasouth announces new manufacturing deal
Staff reporters | Mon, 27 Jun 2022

The medicinal cannabis company has signed a three-year deal with Harker Herbal Products.

Fletcher wowed analysts at last week’s investor day
Jenny Ruth | Mon, 27 Jun 2022

All five of the analysts’ reports BusinessDesk has seen have either “overweight” or “outperform” investment recommendations on Fletcher shares.

How to survive a bear market
Dan Brunskill | Fri, 24 Jun 2022

Bear markets can be stressful but they also present opportunities for investors, says Salt Funds' Greg Fleming.  

Markets FREE
Index heavyweights pull NZ shares higher
Ella Somers | Thu, 23 Jun 2022

Peter McIntyre, an investment adviser at Craigs Investment Partners, said it had been a “strong performance” in today’s market.

How we can fix New Zealand's ports – Don Braid
Brent Melville | Thu, 23 Jun 2022

The head of the multinational logistics group says having container cranes sitting idle across the country is a waste of assets

Markets Exclusive
Investment platform Stake brings stock lending to NZ
Dan Brunskill | Thu, 23 Jun 2022

The zero-brokerage fee share trading platform is looking for ways to bring in revenue and make its business model more sustainable. 

Fletcher to deliver at least $850m operating earnings in 2023
Jenny Ruth | Thu, 23 Jun 2022

Fletcher Building achieved second-half profit margins of 9.5%, just below its target of 10% by the 2023 financial year.

Markets market close
NZ shares fall as Eroad near all-time low
Dan Brunskill | Wed, 22 Jun 2022

Eroad had a second day as the index’s biggest decliner, falling more than 5% to $1.57 and bringing its decline over the past year to almost 75%.

Fletcher said Gib orders reached double capacity
Staff reporters | Wed, 22 Jun 2022

Fletcher's new plant at Tauriko, due to open next year, will increase industry capacity by 30%.

Craigs recommends investors be ‘overweight’ Fletcher shares
Jenny Ruth | Wed, 22 Jun 2022

Even under a “bear-case scenario”, the house building pipeline should support Fletcher’s medium-to-long-term performance.

Markets FREE
NZ shares rise as recession fears ease
Ella Somers | Tue, 21 Jun 2022

Some investors in NZ’s market took the opportunity to buy up “beaten up” stock on the index today, Devon Funds' Greg Smith said.

Markets market close
NZ shares flat as recession risk puts investors off trading
Dan Brunskill | Mon, 20 Jun 2022

Trading volumes were unusually light, with US markets closed tonight for a national holiday.

NZSA, Simplicity call for Fletcher chair Bruce Hassall to resign
Jenny Ruth | Mon, 20 Jun 2022

The shareholder representatives say the Fletcher board must bear ultimate responsibility for the company’s poor performance and the Gib plasterboard shortage.

NZME makes up for slow buyback with $10m special dividend
Dan Brunskill | Mon, 20 Jun 2022

NZME has only spent $5.3m of the $30m set aside for share buybacks. 

Macquarie says Australian banks are profiting from low term deposit rates
Dan Brunskill | Mon, 20 Jun 2022

Are banks being too slow to raise term deposit rates? Some analysts say yes. 

Markets Market Close
Cautious trading follows week of share market turmoil
Ella Somers | Fri, 17 Jun 2022

Peter McIntyre, an investment adviser at Craigs Investment Partners, says New Zealand’s market has been "reliably well-behaved over the course of the day".

Fabrum open to listing to keep up with hydrogen demand
Brent Melville | Fri, 17 Jun 2022

The firm has doubled its headcount and is looking to raise capital to expand its manufacturing and engineering focus into green hydrogen applications.

Australia's electricity train wreck has lessons for NZ
Ian Llewellyn | Fri, 17 Jun 2022

Meridian says the fact that Australia's electricity market has turned into a train wreck shows its decision to pull out was the right one.

Primary Sector
Government favours Fonterra’s commercial interests: MPI
Jenny Ruth | Fri, 17 Jun 2022

The Ministry for Primary Industries estimated Fonterra’s restructuring would cost the average farmer between $135,000 and $400,000.

HW Richardson takes 'uncommercial' plunge into hydrogen
Brent Melville | Fri, 17 Jun 2022

New Zealand's biggest transport operator plans to have its first 10 dual-fuel hydrogen trucks on the road next year. 

Markets market close
NZ share market climbs as US Federal Reserve hikes interest rates
Dan Brunskill | Thu, 16 Jun 2022

Oanda market analyst Edward Moya said the absence of a Bitcoin rally could be a troubling sign for some investors.

Wounded Sky under pressure to return cash after MediaWorks U-turn
Daniel Dunkley | Thu, 16 Jun 2022

Sky TV and MediaWorks will be brushing themselves off after a bruising response to their proposal scotched a SkyWorks deal.

Sky pulls out of MediaWorks takeover
Daniel Dunkley | Thu, 16 Jun 2022

Sky TV has backed away from a dalliance with radio and outdoor advertising.

Mere mortals: investor confidence ebbs
Dan Brunskill | Thu, 16 Jun 2022

An annual survey of investor confidence shows the market fall has got some people rattled.